OTC Markets OTCQB - Delayed Quote USD

Syra Health Corp. (SYRA)

0.0810
-0.0100
(-10.99%)
At close: June 12 at 8:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
8,087.5160
7,982.0820
5,515.1440
5,617.7060
1,409.9760
Cost of Revenue
6,145.1760
6,329.1190
4,103.2440
4,555.9240
979.6220
Gross Profit
1,942.3400
1,652.9630
1,411.9000
1,061.7820
430.3540
Operating Expense
4,736.6050
5,417.8480
4,299.4990
3,151.4770
433.6340
Operating Income
-2,794.2650
-3,764.8850
-2,887.5990
-2,089.6950
-3.2800
Net Non Operating Interest Income Expense
9.8120
5.6470
-50.7440
-28.4700
0
Pretax Income
-2,784.4530
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Net Income Common Stockholders
-2,784.4530
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Diluted NI Available to Com Stockholders
-2,784.4530
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Basic EPS
-0.32
--
-0.60
-0.36
-0.00
Diluted EPS
-0.32
--
-0.60
-0.36
-0.00
Basic Average Shares
8,824.5370
--
4,877.8610
5,860.4360
7,282.5000
Diluted Average Shares
8,824.5370
--
4,877.8610
7,282.5000
7,282.5000
Total Operating Income as Reported
-2,794.2650
-3,764.8850
-2,887.5990
-2,089.6950
-3.2800
Rent Expense Supplemental
144.2190
142.7250
117.8160
107.0130
31.9920
Total Expenses
10,881.7810
11,746.9670
8,402.7430
7,707.4010
1,413.2560
Net Income from Continuing & Discontinued Operation
-2,784.4530
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Normalized Income
-2,784.4530
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Interest Income
24.5640
21.2470
2.9420
0.0630
0
Interest Expense
14.7520
15.6000
53.6860
28.5330
0
Net Interest Income
9.8120
5.6470
-50.7440
-28.4700
0
EBIT
-2,769.7010
-3,743.6380
-2,884.6570
-2,089.6320
-3.2800
EBITDA
-2,712.7110
-3,680.9000
-2,835.8860
-2,074.7830
-3.0730
Reconciled Cost of Revenue
6,145.1760
6,329.1190
4,103.2440
4,555.9240
979.6220
Reconciled Depreciation
56.9900
62.7380
48.7710
14.8490
0.2070
Net Income from Continuing Operation Net Minority Interest
-2,784.4530
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Normalized EBITDA
-2,712.7110
-3,680.9000
-2,835.8860
-2,074.7830
-3.0730
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/29/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NVOS Novo Integrated Sciences, Inc.
0.0010
0.00%
 
HLYK HealthLynked Corp.
0.0190
+5.56%
 
BMGL Basel Medical Group Ltd
3.4600
-26.38%
 
AGL agilon health, inc.
2.1500
-1.83%
 
NUTX Nutex Health Inc.
122.28
-2.12%
 
NIVF NewGenIvf Group Limited
1.7000
-5.03%
 
MODV ModivCare Inc.
2.9200
-12.57%
 
NAKA Kindly MD, Inc.
13.80
-18.68%